Clinical Trial: A Study Evaluating BAT3306 Compared With Keytruda(R) in NSCLC Cancer Participants

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180862) titled 'A Study Evaluating BAT3306 Compared With Keytruda(R) in NSCLC Cancer Participants' on Aug. 19.

Brief Summary: Comparing the PK similarity of BAT3306 and Keytruda; in NSCLC participants who were completely removed by surgery as an auxiliary treatment

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Carcinoma, Non-Small-Cell Lung

Intervention: DRUG: BAT3306

One vial of 4 mL of concentrate contains 100 mg of BAT3306

DRUG: US-Keytruda(R)

One vial of 4 mL of concentrate contains 100 mg of pembrolizumab

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bio-Thera Solutions

Published by HT Digital Content Services...